| Bioactivity | Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 of <1 µΜ (From patent WO2017136727A2, example 42)[1]. | ||||||||||||
| Name | Eclitasertib | ||||||||||||
| CAS | 2125450-76-0 | ||||||||||||
| Formula | C19H18N6O3 | ||||||||||||
| Molar Mass | 378.38 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Anthony A. ESTRADA, et al. Compounds, compositions and methods. WO2017136727A2. |